JP2018507860A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018507860A5 JP2018507860A5 JP2017544759A JP2017544759A JP2018507860A5 JP 2018507860 A5 JP2018507860 A5 JP 2018507860A5 JP 2017544759 A JP2017544759 A JP 2017544759A JP 2017544759 A JP2017544759 A JP 2017544759A JP 2018507860 A5 JP2018507860 A5 JP 2018507860A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- binding domain
- seq
- protein
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562121406P | 2015-02-26 | 2015-02-26 | |
| US62/121,406 | 2015-02-26 | ||
| PCT/US2016/019401 WO2016138164A1 (en) | 2015-02-26 | 2016-02-24 | A vaccine composition comprising an immunogenic protein and combination adjuvants for use in eliciting antigen-specific t-cell responses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018507860A JP2018507860A (ja) | 2018-03-22 |
| JP2018507860A5 true JP2018507860A5 (https=) | 2018-12-20 |
Family
ID=56789742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017544759A Pending JP2018507860A (ja) | 2015-02-26 | 2016-02-24 | 抗原特異的ｔ細胞反応を誘発するための、免疫原性タンパク質及びアジュバントの組み合わせを含むワクチン組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9775898B2 (https=) |
| EP (1) | EP3261667A4 (https=) |
| JP (1) | JP2018507860A (https=) |
| KR (1) | KR20170105107A (https=) |
| CN (1) | CN107249629A (https=) |
| BR (1) | BR112017018017A2 (https=) |
| IL (1) | IL254110A0 (https=) |
| RU (1) | RU2017129818A (https=) |
| TW (1) | TWI674269B (https=) |
| WO (1) | WO2016138164A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3515929B1 (en) * | 2016-09-19 | 2021-05-05 | TheVax Genetics Vaccine Co., Ltd. | Hepatitis b therapeutic vaccines |
| WO2019133647A1 (en) * | 2017-12-29 | 2019-07-04 | Thevax Genetics Vaccine Co., Ltd. | Combination of a fusion protein vaccine with anti-ox40 antibody for use in eliciting antigen-specific immune responses |
| CN113527511A (zh) * | 2018-09-19 | 2021-10-22 | 天康生物股份有限公司 | 融合蛋白及其制备方法、应用、表达系统和疫苗 |
| CN109663126A (zh) * | 2019-03-01 | 2019-04-23 | 龙阔（苏州）生物工程有限公司 | 一种疫苗佐剂及其应用及猪繁殖与呼吸综合征疫苗 |
| US20210100887A1 (en) * | 2019-10-04 | 2021-04-08 | Reber Genetics Co., Ltd. | Recombinant fusion protein and immunogenic composition |
| CN112972671B (zh) * | 2019-12-13 | 2024-04-19 | 远大赛威信生命科学(南京)有限公司 | 药物组合物及其用途 |
| CN116096733A (zh) * | 2020-04-10 | 2023-05-09 | 阿卡斯通生物科学公司 | Covid-19融合蛋白的抗原特异性免疫疗法和使用方法 |
| AU2021268885B2 (en) * | 2020-05-06 | 2025-02-20 | Navicure Biopharmaceuticals Limited | Fusion proteins for immunotherapy against cancer and infectious diseases |
| CN111548395A (zh) * | 2020-05-25 | 2020-08-18 | 中国农业科学院兰州兽医研究所 | 一种口蹄疫病毒二价多表位重组病毒样颗粒及其应用 |
| CN112626073B (zh) * | 2020-10-26 | 2021-06-15 | 中国科学院昆明动物研究所 | 一种对PRRSV具有特异性免疫刺激作用的CpG-ODN及其应用 |
| CN119912535A (zh) * | 2021-12-28 | 2025-05-02 | 成都迈科康生物科技有限公司 | 一种hpv抗原及其相关产品 |
| CN114835822B (zh) * | 2022-04-22 | 2022-11-04 | 浙江洪晟生物科技股份有限公司 | 猪瘟病毒的多聚体疫苗及其制备方法 |
| WO2025180443A1 (en) * | 2024-02-29 | 2025-09-04 | Immunadd Inc. | Adjuvant composition, pharmaceutical composition comprising the same, and method for preventing or treating disease caused by viral infection, bacterial infection, protozoal infection or cancer |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0671948T3 (da) * | 1992-06-25 | 1997-09-01 | Smithkline Beecham Biolog | Vaccinepræparat indeholdende adjuvanser |
| US5712149A (en) * | 1995-02-03 | 1998-01-27 | Cell Genesys, Inc. | Chimeric receptor molecules for delivery of co-stimulatory signals |
| US7049302B1 (en) * | 1998-08-10 | 2006-05-23 | Antigenics Inc. | Compositions of CPG and saponin adjuvants and uses thereof |
| PL378001A1 (pl) * | 2003-01-29 | 2006-02-20 | Pfizer Products Inc. | Szczepionki przeciw Bordetella bronchiseptica dla psów |
| EP1594437A2 (en) | 2003-02-04 | 2005-11-16 | University of Connecticut Health Center | Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| AU2003272065A1 (en) * | 2003-04-03 | 2004-10-25 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof |
| MX2009002893A (es) * | 2006-09-18 | 2009-07-10 | Raptor Pharmaceutical Inc | Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap). |
| EP2078726A1 (en) * | 2008-01-09 | 2009-07-15 | Vision 7 GmbH | Secretable HIV entry inhibitory peptides for therapy of HIV infection |
| CN101969975B (zh) * | 2008-01-31 | 2013-06-05 | 生控基因疫苗股份有限公司 | 作为疫苗的hiv嵌合融合蛋白 |
| CA2734950A1 (en) | 2008-08-28 | 2010-03-04 | Glaxosmithkline Biologicals S.A. | Vaccine |
| WO2010118424A2 (en) * | 2009-04-10 | 2010-10-14 | The Johns Hopkins University | Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines |
| EP2575868A1 (en) * | 2010-06-07 | 2013-04-10 | Pfizer Vaccines LLC | Ige ch3 peptide vaccine |
| PL391627A1 (pl) * | 2010-06-25 | 2012-01-02 | Adamed Spółka Z Ograniczoną Odpowiedzialnością | Przeciwnowotworowe białko fuzyjne |
| MX350927B (es) * | 2010-08-26 | 2017-09-26 | Toray Ind Inc Star | Composicion inmunogenica. |
| RU2631002C2 (ru) * | 2012-12-05 | 2017-09-15 | Тевакс Дженетикс Вэксин Ко., Лтд. | Слитые белки для применения в качестве иммуногенных усиливающих агентов для индуцирования антигенспецифического т-клеточного ответа |
| WO2015002954A1 (en) | 2013-07-03 | 2015-01-08 | Synglyco Pharmaceuticals, Inc. | Synthetic oligosaccharides for p. aeruginosa vaccine |
| US20150037374A1 (en) * | 2013-07-31 | 2015-02-05 | Csl Limited | Anti-tumor compositions and uses thereof |
| EP3515929B1 (en) * | 2016-09-19 | 2021-05-05 | TheVax Genetics Vaccine Co., Ltd. | Hepatitis b therapeutic vaccines |
-
2016
- 2016-02-24 KR KR1020177023587A patent/KR20170105107A/ko not_active Ceased
- 2016-02-24 JP JP2017544759A patent/JP2018507860A/ja active Pending
- 2016-02-24 US US15/052,713 patent/US9775898B2/en not_active Expired - Fee Related
- 2016-02-24 RU RU2017129818A patent/RU2017129818A/ru not_active Application Discontinuation
- 2016-02-24 BR BR112017018017A patent/BR112017018017A2/pt not_active IP Right Cessation
- 2016-02-24 EP EP16756299.0A patent/EP3261667A4/en not_active Withdrawn
- 2016-02-24 CN CN201680011623.6A patent/CN107249629A/zh active Pending
- 2016-02-24 WO PCT/US2016/019401 patent/WO2016138164A1/en not_active Ceased
- 2016-02-25 TW TW105105741A patent/TWI674269B/zh active
-
2017
- 2017-08-23 IL IL254110A patent/IL254110A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018507860A5 (https=) | ||
| RU2017129818A (ru) | Композиция вакцины, содержащая иммуногенный белок и комбинированные адъюванты, для применения в стимулировании антигенспецифичных т-клеточных ответов | |
| EP2928491B1 (en) | Fusion proteins for use as immunogenic enhancers for inducing antigen-specific t cell responses | |
| JP2016199557A5 (https=) | ||
| JP2016510983A5 (https=) | ||
| JP2015509707A5 (https=) | ||
| Donaldson et al. | Virus-like particles, a versatile subunit vaccine platform | |
| JP2014530003A5 (https=) | ||
| JP2016519658A5 (https=) | ||
| JP2013526849A5 (https=) | ||
| JP2015212284A5 (https=) | ||
| ES2790527T3 (es) | Composiciones de vacunas contra el síndrome reproductivo y respiratorio porcino y las enfermedades asociadas al circovirus porcino | |
| JP2021502807A5 (https=) | ||
| IL274130B1 (en) | HIV–1 vaccine immunogens with novel scaffolds | |
| JP2016520534A5 (https=) | ||
| JP2018501258A5 (https=) | ||
| RU2007147938A (ru) | Конъюгаты антигенов и их применение | |
| ES3030310T1 (en) | Sars-cov-2 subunit vaccine | |
| WO2010088393A3 (en) | Li-kay hybrid peptides that modulate the immune response to influenza | |
| CU24751B1 (es) | Antígeno recombinante para la inducción de respuesta inmune contra el virus zika | |
| NZ751943A (en) | Hepatitis c virus immunogenic compositions and methods of use thereof | |
| TH114418A (th) | วัคซีน | |
| NZ751943B2 (en) | Hepatitis c virus immunogenic compositions and methods of use thereof |